Dr. Sanja Tomovska

Dr. Sanja Tomovska is a seasoned expert in the fields of biotechnology, medicine, and health strategy, currently serving on the International Advisory Board at Humansa since February 2024. As Founder and CEO of Quant Biomarkers AG since December 2021, Sanja focuses on advancing biomarker technologies for early detection of chronic diseases. Sanja also holds strategic roles at Rambam AG Expert Systems Accelerator, P|X|M Precise X MED, and the Virtual Advisory Board as Country Chair for Switzerland. Prior experience includes leadership positions at Abbott and Novartis, where Sanja managed global strategies in neuroscience and therapeutic areas. Education includes a PhD in Molecular Biology from the University of Basel and a Certificate in Finance Analytics from INSEAD.